Skip to main content
. Author manuscript; available in PMC: 2021 Jul 19.
Published in final edited form as: BJU Int. 2019 Jun 26;124(5):768–774. doi: 10.1111/bju.14835

Table 1.

Patients referred with low-grade (GG1 and GG2) PCa and resulting confirmatory fusion biopsy.

Race Outside SB Confirmatory FB
Gleason Group (n) No Cancer, n (%) GG 1, n (%) GG 2, n (%) ≥ GG 3, n (%)
AA men African-American (84) 1 (72) 14 (19.4) 20 (27.8) 22 (30.6) 16 (22.2)
2 (12) 2 (16.7) 1 (8.3) 4 (33.3) 5 (41.7)
Non-AA men Caucasian (431) 1 (373) 92 (24.7) 124 (33.2) 112 (30.0) 45 (12.1)
2 (58) 8 (13.7) 7 (12.1) 30 (51.7) 13 (22.4)
Other (27) 1 (21) 4 (19.0) 7 (33.3) 5 (23.8) 5 (23.8)
2 (6) 0 (0.0) 2 (33.3) 3 (50.0) 1 (16.7)

AA = African-American, GG = Gleason Grade Group, SB = Systematic Biopsy, FB = Fusion Biopsy